Sapico FL, Canawati HN, Witte JL, et al: The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. .Rev Infect Dis6: (suppl 1):S171. ,1984. .6718934)| false
Faglia E, Favales F, Adelgi A, et al: Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. .Diabetes Care19::1338. ,1996. .
Faglia E, Favales F, Adelgi A, et al: Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. .Diabetes Care19::1338. ,1996. .8941460)| false
Hertzer NR: Fatal myocardial infarction following lower extremity revascularization: two hundred seventy-three patients followed six to eleven postoperative years. .Ann Surg193::492. ,1981. .7212811)| false
The purpose of this article is to present reference guidelines to assist clinicians when treating diabetic patients with foot wounds. Diabetic patients with limb-threatening foot ulcers often have multiple coexisting medical conditions that frequently become impediments to the resolution of foot wounds. Each foot wound is unique and its etiology is multifactorial; therefore, each foot wound should be managed differently. The treatment algorithm presented in this article is divided into three categories: Algorithm I describes the treatment of septic foot wounds, which may be considered true podiatric surgical emergencies; Algorithm II describes the treatment of ischemic foot ulcers or gangrene with or without underlying osteomyelitis; and Algorithm III describes the treatment of neuropathic foot ulcers with or without underlying osteomyelitis. (J Am Podiatr Med Assoc 92(6): 336-349, 2002)
Mailing address: 2621 S Bristol St, Ste 209, Santa Ana, CA 92704.